Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

1 Dec 1999

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunodeficiency and Autoimmune Disorders
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10648924
DOI: 10.1016/s0022-1759(99)00137-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodiesPMID 10648924Read ↗

Transgenic Mouse Strains as Platforms for the Successful Discovery and Development of Human Therapeutic Monoclonal AntibodiesSemantic proximity Read ↗

Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeuticsSemantic proximity Read ↗

Discovery and bio‐optimization of human antibody therapeutics using the XenoMouse® transgenic mouse platformSemantic proximity Read ↗

Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human AntibodiesSemantic proximity Read ↗

From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceSemantic proximity Read ↗

Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discoverySemantic proximity Read ↗

Engineering Fully Human Monoclonal Antibodies from Murine Variable RegionsSemantic proximity Read ↗

High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic miceSemantic proximity Read ↗

Non-germline genetically engineered mouse models for translational cancer researchSemantic proximity Read ↗

Foundation Review: Transgenic animals and their impact on the drug discovery industrySemantic proximity Read ↗

Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo MouseSemantic proximity Read ↗

Criteria to make animal studies more relevant to treating human cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.